Zobrazeno 1 - 10
of 29
pro vyhledávání: '"S G, Abbasova"'
Autor:
Yu. A. Nikonova, S. G. Abbasova, P. E. Kargopolova, O. M. Strizhakova, I. V. Lyagoskin, A. P. Vasilev, A. S. Pershin
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 14, Iss 3, Pp 317-329 (2024)
INTRODUCTION. Bioanalytical techniques are characterised by greater variability and lower stability than physicochemical methods because live test systems are inherently labile. Since regulatory standards do not establish a unified approach, the sele
Externí odkaz:
https://doaj.org/article/ee387463937542498c2e3d73d9b3ce55
Autor:
D. A. Poteryaev, S. G. Abbasova, P. E. Ignatyeva, O. M. Strizhakova, S. V. Kolesnik, R. A. Khamitov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 21, Iss 3, Pp 178-192 (2021)
With the onset of the COVID-19 pandemic, a number of molecular-based tests have been developed to diagnose SARS-CoV-2 infection. However, numerous available serological tests lack sufficient sensitivity or specificity. They do not detect specific ant
Externí odkaz:
https://doaj.org/article/4cb802dafa41407c80ad4f74e8dacd73
Autor:
I. V. Lyagoskin, M. S. Pantyushenko, O. M. Strizhakova, N. K. Kudina, E. Yu. Prudnikova, P. V. Chichkanova, S. G. Abbasova
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 20, Iss 1, Pp 42-49 (2020)
Enzyme replacement therapy (ERT) is one of the most efficient treatments for lysosomal storage diseases. Type 1 Gaucher disease is caused by β-glucocerebrosidase enzyme deficiency, which may be compensated for by intravenous infusions of imigluceras
Externí odkaz:
https://doaj.org/article/a507e5c6a71d4d2386c1c73253d6fa87
Autor:
M. S. Aksenova, E. N. Bocharova, S. G. Abbasova, A. S. Ponomarev, V. V. Loginova, M. V. Bolotnikova, N. V. Belskaya, A. A. Kazarov, A. E. Lisova, N. K. Kudina, M. S. Pantyushenko, M. V. Zhilyaeva, D. S. Kopein, Yu. M. Karelov, G. G. Erastov, M. V. Lykov, R. A. Chamitov
Publikováno v:
Journal Biomed. 19:47-60
This work presents research studies into the comparability of Tigerase® (inhalation solution, manufactured by JSC «GENERIUM», Russia) to the reference drug Pulmozim® (inhalation solution, manufactured by Hoffmann-La Roche Ltd., Switzerland). Both
Autor:
E. Yu. Prudnikova, G. N. Poroshin, N. K. Kudina, I. V. Lyagoskin, E. V. Sazonova, A. Yu. Vishnevskiy, S. G. Abbasova
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 4, Iss 6, Pp 54-71 (2017)
Bioanalytical methods are applied at the development and test of drugs as well as at the step of pharmaceutic products issue. Drugs and excipients quality estimation is made by means of precise and reproducible methods. Accuracy and reproducibility o
Externí odkaz:
https://doaj.org/article/128c2ea0036f46ee9feb019547551465
Autor:
E. Yu. Prudnikova, G. N. Poroshin, N. K. Kudina, I. V. Lyagoskin, E. V. Sazonova, A. Yu. Vishnevskiy, S. G. Abbasova
Publikováno v:
Farmaciâ i Farmakologiâ (Pâtigorsk), Vol 4, Iss 6, Pp 54-71 (2017)
Bioanalytical methods are applied at the development and test of drugs as well as at the step of pharmaceutic products issue. Drugs and excipients quality estimation is made by means of precise and reproducible methods. Accuracy and reproducibility o
Publikováno v:
Moscow University Chemistry Bulletin. 66:241-246
A plasmid encoding a fusion protein (4TS-bccp87) composed of a thermostable mutant of the Luciola mingrelica firefly luciferase (4TS) and 87 carboxy-terminal amino acid residues of the biotin-binding domain (bccp87) from E. coli was constructed using
Autor:
Yu. V. Vertiev, S. G. Abbasova, I. D. Vinogradova, M. V. Kapralova, E. V. Grishin, V. A. Nesmeyanov, Natalia V. Rudenko, A. Yu. Gorokhovatskii
Publikováno v:
Russian Journal of Bioorganic Chemistry. 37:307-315
Mouse monoclonal antibodies to health-threatening botulinum neurotoxins (BoNTs) of types A, B, E, and F have been produced and characterized. The antibodies are capable of interacting with a toxin inside the respective natural toxic complex. A sandwi
Autor:
M. A. Digaeva, Z. K. Karabekova, M. N. Obusheva, M. M. Vysotskii, L. K. Ovchinnikova, I. B. Manuchin, K. A. Bahoeva, S. G. Abbasova, T. A. Britvin, U. R. Mamedov, M. I. Davidov, I. A. Kazantzeva
Publikováno v:
Bulletin of Experimental Biology and Medicine. 148:638-642
A test system developed by the authors was used to measure serum concentrations of soluble Fas in patients with malignant and benign tumors of different location and morphology. Relationships between soluble Fas levels and the main clinical and morph
Autor:
T. A. Britvin, D. A. Pirogov, S. G. Abbasova, G. S. Molchanova, N. E. Kushlinskii, Valery M. Lipkin, A. P. Kalinin, A. A. Baronini, V. Yu. Sel’chuk, R. S. Tishenina, O. P. Bogatyrev, G. A. Polyakova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 134:171-174
We compared plasma content of soluble Fas antigen (sFas) in 59 patients with tumors and tumor-like pathologies of the adrenal cortex and medulla and 60 healthy donors (control). The incidence and content of sFas in the plasma from patients with adren